Exactech Company Profile (NASDAQ:EXAC)

About Exactech (NASDAQ:EXAC)

Exactech logoExactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:EXAC
  • CUSIP: 30064E10
  • Web: www.exac.com
  • Market Cap: $456.04 million
  • Outstanding Shares: 14,348,000
Average Prices:
  • 50 Day Moving Avg: $31.79
  • 200 Day Moving Avg: $30.04
  • 52 Week Range: $22.20 - $34.25
  • Trailing P/E Ratio: 3190.00
  • Foreward P/E Ratio: 21.70
  • P/E Growth: 2.51
Sales & Book Value:
  • Annual Revenue: $262.96 million
  • Price / Sales: 1.74
  • Book Value: $16.44 per share
  • Price / Book: 1.94
  • EBITDA: $43.51 million
  • Net Margins: 0.30%
  • Return on Equity: 7.39%
  • Return on Assets: 5.98%
  • Debt-to-Equity Ratio: 0.06%
  • Current Ratio: 4.15%
  • Quick Ratio: 2.18%
  • Average Volume: 30,586 shs.
  • Beta: 1.01
  • Short Ratio: 4.2

Frequently Asked Questions for Exactech (NASDAQ:EXAC)

What is Exactech's stock symbol?

Exactech trades on the NASDAQ under the ticker symbol "EXAC."

How were Exactech's earnings last quarter?

Exactech, Inc. (NASDAQ:EXAC) announced its earnings results on Thursday, July, 27th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.33. The company earned $67.30 million during the quarter, compared to analyst estimates of $67.75 million. Exactech had a net margin of 0.30% and a return on equity of 7.39%. The firm's quarterly revenue was up 1.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.31 earnings per share. View Exactech's Earnings History.

When will Exactech make its next earnings announcement?

Exactech is scheduled to release their next quarterly earnings announcement on Monday, October, 30th 2017. View Earnings Estimates for Exactech.

What guidance has Exactech issued on next quarter's earnings?

Exactech issued an update on its third quarter earnings guidance on Thursday, October, 12th. The company provided EPS guidance of $0.19-0.21 for the period, compared to the Thomson Reuters consensus estimate of $0.24. The company issued revenue guidance of $61.4 million (prior: $60.5-62.5 million), compared to the consensus revenue estimate of $61.64 million.

Where is Exactech's stock going? Where will Exactech's stock price be in 2017?

2 brokers have issued 1-year price objectives for Exactech's stock. Their predictions range from $34.00 to $34.00. On average, they expect Exactech's share price to reach $34.00 in the next year. View Analyst Ratings for Exactech.

Who are some of Exactech's key competitors?

Who are Exactech's key executives?

Exactech's management team includes the folowing people:

  • R. William Petty M.D., Executive Chairman of the Board
  • David W. Petty, Chief Executive Officer, President and Director
  • Joel C. Phillips CPA, Chief Financial Officer, Executive Vice President, Treasurer
  • Bruce E. Thompson, Senior Vice President , General manager- Biologics and Spine Division
  • Gary J. Miller Ph.D., Executive Vice President - Research and Development
  • Donna M. Edwards, Vice President, Legal and General Counsel
  • Betty A. Petty, Vice President - Administration, Corporate Secretary
  • James G. Binch, Independent Director
  • W. Andrew Krusen Jr., Independent Director
  • William B. Locander Ph.D., Independent Director

How do I buy Exactech stock?

Shares of Exactech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exactech's stock price today?

One share of Exactech stock can currently be purchased for approximately $31.90.

MarketBeat Community Rating for Exactech (NASDAQ EXAC)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  209
MarketBeat's community ratings are surveys of what our community members think about Exactech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Exactech (NASDAQ:EXAC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $34.00 (6.58% upside)
Consensus Price Target History for Exactech (NASDAQ:EXAC)
Price Target History for Exactech (NASDAQ:EXAC)
Analysts' Ratings History for Exactech (NASDAQ:EXAC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/15/2017Robert W. BairdSet Price TargetBuy$34.00N/AView Rating Details
7/31/2017GabelliReiterated RatingBuyHighView Rating Details
10/28/2015Northland SecuritiesLower Price TargetMarket Perform$22.00 -> $20.00N/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for Exactech (NASDAQ:EXAC)
Earnings by Quarter for Exactech (NASDAQ:EXAC)
Earnings History by Quarter for Exactech (NASDAQ EXAC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017$0.24N/AView Earnings Details
7/27/2017Q2 2017$0.33$0.33$67.75 million$67.30 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.31$0.34$67.05 million$69.48 millionViewN/AView Earnings Details
2/21/2017Q416$0.32$0.34$66.00 million$66.20 millionViewListenView Earnings Details
10/31/2016Q316$0.22$0.22$58.69 million$59.90 millionViewN/AView Earnings Details
8/1/2016Q216$0.30$0.31$64.18 million$66.10 millionViewN/AView Earnings Details
4/26/2016Q116$0.29$0.31$63.63 million$65.30 millionViewN/AView Earnings Details
2/16/2016Q415$0.28$0.29$61.29 million$62.70 millionViewListenView Earnings Details
10/27/2015Q315$0.23$0.20$58.46 million$56.20 millionViewListenView Earnings Details
7/28/2015Q215$0.27$0.26$62.13 million$61.50 millionViewListenView Earnings Details
4/28/2015Q115$0.30$0.29$63.71 million$61.40 millionViewN/AView Earnings Details
2/17/2015Q414$0.33$0.36$63.30 million$63.30 millionViewN/AView Earnings Details
10/21/2014Q314$0.25$0.21$58.60 million$57.90 millionViewN/AView Earnings Details
7/28/2014Q214$0.30$0.30$63.80 million$63.92 millionViewN/AView Earnings Details
4/21/2014Q114$0.29$0.30$63.05 million$63.30 millionViewN/AView Earnings Details
2/19/2014Q413$0.31$0.33$63.20 million$61.60 millionViewN/AView Earnings Details
10/22/2013Q313$0.21$0.23$55.36 million$55.70 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.25$0.27$58.42 million$60.60 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.28$0.29$58.20 million$59.30 millionViewN/AView Earnings Details
10/30/2012Q312$0.17$0.19$50.20 million$51.30 millionViewN/AView Earnings Details
7/31/2012$0.23$0.23ViewN/AView Earnings Details
5/1/2012$0.23$0.25ViewN/AView Earnings Details
2/28/2012$0.25$0.18ViewN/AView Earnings Details
11/1/2011$0.20$0.15ViewN/AView Earnings Details
8/2/2011$0.26$0.28ViewN/AView Earnings Details
5/3/2011$0.27$0.28ViewN/AView Earnings Details
2/28/2011$0.23$0.23ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Exactech (NASDAQ:EXAC)
Current Year EPS Consensus Estimate: $1.29 EPS
Next Year EPS Consensus Estimate: $1.47 EPS


Dividend History for Exactech (NASDAQ:EXAC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Exactech (NASDAQ:EXAC)
Insider Ownership Percentage: 28.30%
Institutional Ownership Percentage: 64.58%
Insider Trades by Quarter for Exactech (NASDAQ:EXAC)
Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)
Insider Trades by Quarter for Exactech (NASDAQ:EXAC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/8/2017Fern WattsDirectorSell1,013$29.04$29,417.52View SEC Filing  
8/4/2017James G BinchDirectorSell747$28.40$21,214.80View SEC Filing  
5/31/2017William B LocanderDirectorSell988$30.34$29,975.92View SEC Filing  
5/23/2017Joel C PhillipsCFOSell7,610$30.71$233,703.10View SEC Filing  
3/9/2017Fern WattsDirectorSell1,000$24.25$24,250.00View SEC Filing  
3/8/2017James G BinchDirectorSell3,588$24.16$86,686.08View SEC Filing  
2/24/2017Bruce E ThompsonSVPSell4,906$24.77$121,521.62View SEC Filing  
11/3/2016James G BinchDirectorSell600$22.61$13,566.00View SEC Filing  
8/25/2016Fern WattsDirectorSell1,100$27.68$30,448.00View SEC Filing  
8/22/2016Bruce E ThompsonSVPSell1,433$27.97$40,081.01View SEC Filing  
8/19/2016David W PettyCEOSell3,550$27.75$98,512.50View SEC Filing  
7/1/2016Joel C PhillipsCFOSell3,000$26.75$80,250.00View SEC Filing  
6/8/2016Gary J MillerEVPSell9,800$25.16$246,568.00View SEC Filing  
6/7/2016Bruce E ThompsonSVPSell2,000$25.07$50,140.00View SEC Filing  
6/3/2016James G BinchDirectorSell600$24.86$14,916.00View SEC Filing  
6/2/2016Gary J MillerEVPSell3,381$25.11$84,896.91View SEC Filing  
5/25/2016Gary J MillerEVPSell9,319$25.10$233,906.90View SEC Filing  
5/18/2016Gary J MillerEVPSell9,664$24.37$235,511.68View SEC Filing  
5/9/2016Joel C PhillipsCFOSell3,900$23.13$90,207.00View SEC Filing  
5/5/2016James G BinchDirectorSell1,870$23.00$43,010.00View SEC Filing  
5/3/2016Fern WattsDirectorSell2,000$22.76$45,520.00View SEC Filing  
4/29/2016Betty A PettyVPSell18,000$22.65$407,700.00View SEC Filing  
4/27/2016Gary J MillerEVPSell9,851$24.06$237,015.06View SEC Filing  
4/26/2016Gary J MillerEVPSell7,985$23.11$184,533.35View SEC Filing  
4/25/2016Gary J MillerEVPSell4,725$23.14$109,336.50View SEC Filing  
3/31/2016Gary J MillerEVPSell7,000$19.95$139,650.00View SEC Filing  
3/10/2016Joel C PhillipsCFOSell2,000$18.58$37,160.00View SEC Filing  
3/8/2016Betty A PettyVPSell15,964$19.06$304,273.84View SEC Filing  
3/7/2016Donna M EdwardsVPSell10,000$18.85$188,500.00View SEC Filing  
3/3/2016Gary J MillerEVPSell7,017$19.23$134,936.91View SEC Filing  
3/3/2016William B LocanderDirectorSell2,435$19.25$46,873.75View SEC Filing  
12/10/2015James G BinchDirectorSell1,500$17.03$25,545.00View SEC Filing  
12/9/2015Fern WattsDirectorSell1,200$17.32$20,784.00View SEC Filing  
12/1/2015Bruce E. ThompsonSVPSell21,904$17.57$384,853.28View SEC Filing  
11/24/2015Bruce E. ThompsonSVPSell900$17.75$15,975.00View SEC Filing  
9/1/2015Bruce E. ThompsonSVPSell2,107$19.45$40,981.15View SEC Filing  
5/28/2015Joel C PhillipsCFOSell5,000$21.76$108,800.00View SEC Filing  
5/20/2015William B LocanderDirectorSell3,350$21.50$72,025.00View SEC Filing  
5/18/2015Fern WattsDirectorSell2,200$21.21$46,662.00View SEC Filing  
5/4/2015Joel C PhillipsCFOSell2,700$21.67$58,509.00View SEC Filing  
3/20/2015Gary J MillerEVPSell32,800$24.95$818,360.00View SEC Filing  
2/24/2015R William PettyChairmanSell45,067$23.08$1,040,146.36View SEC Filing  
2/2/2015Betty A PettyVPSell7,500$20.74$155,550.00View SEC Filing  
1/8/2015Gary J MillerEVPSell4,145$23.17$96,039.65View SEC Filing  
12/3/2014Gary J MillerEVPSell5,000$21.83$109,150.00View SEC Filing  
11/25/2014Betty A PettyMajor ShareholderSell12,500$21.86$273,250.00View SEC Filing  
11/25/2014Bruce E ThompsonSVPSell6,500$22.05$143,325.00View SEC Filing  
10/31/2014Joel C PhillipsCFOSell5,000$21.44$107,200.00View SEC Filing  
9/5/2014R William PettyMajor ShareholderSell25,000$23.68$592,000.00View SEC Filing  
8/25/2014Albert H BursteinDirectorSell8,852$23.73$210,057.96View SEC Filing  
7/1/2014Gary J MillerEVPSell12,392$26.21$324,794.32View SEC Filing  
6/26/2014Gary J MillerEVPSell1,894$25.06$47,463.64View SEC Filing  
6/25/2014Gary J MillerEVPSell16,356$25.33$414,297.48View SEC Filing  
6/10/2014Joel C PhillipsCFOSell5,000$24.77$123,850.00View SEC Filing  
6/5/2014Bruce E ThompsonSVPSell1,667$23.50$39,174.50View SEC Filing  
6/5/2014Joel C PhillipsCFOSell5,000$23.21$116,050.00View SEC Filing  
5/29/2014Bruce E ThompsonSVPSell1,588$23.00$36,524.00View SEC Filing  
5/12/2014David PettyCEOSell10,287$20.99$215,924.13View SEC Filing  
5/8/2014David PettyCEOSell7,976$21.51$171,563.76View SEC Filing  
4/24/2014Bruce ThompsonSVPSell2,412$23.78$57,357.36View SEC Filing  
4/23/2014William LocanderDirectorSell4,500$23.18$104,310.00View SEC Filing  
2/28/2014William LocanderDirectorSell1,819$23.16$42,128.04View SEC Filing  
12/5/2013R William PettyCEOSell10,000$23.67$236,700.00View SEC Filing  
11/12/2013Bruce ThompsonSVPSell3,079$23.35$71,894.65View SEC Filing  
8/22/2013William LocanderDirectorSell1,521$19.05$28,975.05View SEC Filing  
7/15/2013Gary J MillerEVPSell10,250$20.07$205,717.50View SEC Filing  
7/8/2013Gary J MillerEVPSell1,000$20.00$20,000.00View SEC Filing  
6/17/2013Gary J MillerEVPSell8,125$18.98$154,212.50View SEC Filing  
6/5/2013R William PettyCEOSell3,885$18.00$69,930.00View SEC Filing  
6/4/2013R William PettyCEOSell14,257$18.01$256,768.57View SEC Filing  
5/28/2013R William PettyCEOSell20,000$18.21$364,200.00View SEC Filing  
5/22/2013R William PettyCEOSell11,493$18.13$208,368.09View SEC Filing  
5/17/2013R William PettyCEOSell17,472$18.05$315,369.60View SEC Filing  
5/16/2013R William PettyCEOSell22,893$18.22$417,110.46View SEC Filing  
5/9/2013R William PettyCEOSell10,000$18.25$182,500.00View SEC Filing  
5/8/2013David W PettyPresidentSell8,000$18.35$146,800.00View SEC Filing  
12/4/2012R William PettyCEOSell14,048$16.29$228,841.92View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Exactech (NASDAQ:EXAC)
Latest Headlines for Exactech (NASDAQ:EXAC)
bizjournals.com logoHip Reconstruction Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2022
www.bizjournals.com - October 18 at 12:19 AM
americanbankingnews.com logoFinancial Analysis: Exactech (EXAC) & Invacare Corporation (IVC)
www.americanbankingnews.com - October 13 at 10:32 AM
streetinsider.com logoExactech (EXAC) Lowers Q3 EPS Guidance by ~$0.04 Due to Impact of Hurricanes Irma & Harvey
www.streetinsider.com - October 13 at 5:27 AM
reuters.com logoBRIEF-Exactech Inc estimates impact from recent hurricanes
www.reuters.com - October 12 at 7:21 PM
finance.yahoo.com logoExactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call
finance.yahoo.com - October 12 at 7:21 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Updates Q3 Earnings Guidance
www.americanbankingnews.com - October 12 at 5:16 PM
finance.yahoo.com logoETFs with exposure to Exactech, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 6:48 PM
americanbankingnews.com logoHead-To-Head Survey: Exactech (EXAC) vs. Syneron Medical (ELOS)
www.americanbankingnews.com - October 7 at 7:36 AM
finance.yahoo.com logoExactech, Inc. :EXAC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 6:53 PM
finance.yahoo.com logoOrthobiologics Market by Product, by End-User - Global Forecast to 2019
finance.yahoo.com - October 4 at 5:20 PM
prnewswire.com logoEurope Orthobiologics Market by Product, by End-User, by Geography - Analysis & Forecast to 2019
www.prnewswire.com - October 4 at 5:20 PM
finanznachrichten.de logoGlobal $25 Bn Artificial Joints Market, 2025
www.finanznachrichten.de - October 4 at 8:57 AM
americanbankingnews.com logoHead-To-Head Comparison: Exactech (EXAC) vs. Steris Plc (STE)
www.americanbankingnews.com - October 2 at 8:33 AM
americanbankingnews.com logoHead to Head Review: Exactech (EXAC) vs. SeaSpine Holdings Corporation (SPNE)
www.americanbankingnews.com - September 16 at 6:30 PM
americanbankingnews.com logoHead-To-Head Contrast: Exactech (EXAC) & Transenterix (TRXC)
www.americanbankingnews.com - September 14 at 6:04 PM
prnewswire.com logoGlobal Knee Reconstruction Market Value to Reach US$9.4 Bn by 2022 - Future Market Insights
www.prnewswire.com - September 13 at 7:52 PM
finance.yahoo.com logoExactech, Inc. breached its 50 day moving average in a Bullish Manner : EXAC-US : September 11, 2017
finance.yahoo.com - September 11 at 7:05 PM
americanbankingnews.com logoAnalyzing Exactech (EXAC) & CONMED Corporation (CNMD)
www.americanbankingnews.com - September 10 at 12:26 PM
streetinsider.com logoForm 4 EXACTECH INC For: Aug 31 Filed by: KRUSEN W ANDREW JR
www.streetinsider.com - September 6 at 1:10 AM
finance.yahoo.com logoExactech To Present to Investors at Baird 2017 Global Healthcare Conference
finance.yahoo.com - September 5 at 8:10 PM
finance.yahoo.com logoExactech (EXAC) Truliant Knee System Receives IDEA Award
finance.yahoo.com - August 22 at 7:05 PM
finance.yahoo.com logoExactech, Inc. breached its 50 day moving average in a Bullish Manner : EXAC-US : August 21, 2017
finance.yahoo.com - August 21 at 6:01 PM
finance.yahoo.com logoExactech’s Truliant® Knee System Instrumentation Honored with International Design Excellence Award (IDEA®)
finance.yahoo.com - August 21 at 6:01 PM
americanbankingnews.com logoInsider Selling: Exactech, Inc. (NASDAQ:EXAC) Director Sells 1,013 Shares of Stock
www.americanbankingnews.com - August 10 at 8:38 PM
americanbankingnews.com logoExactech, Inc. (NASDAQ:EXAC) Director James G. Binch Sells 747 Shares
www.americanbankingnews.com - August 8 at 8:34 PM
americanbankingnews.com logoMiMedx Group (MDXG) vs. Exactech (NASDAQ:EXAC) Financial Comparison
www.americanbankingnews.com - August 5 at 4:18 PM
finance.yahoo.com logoExactech, Inc. – Value Analysis (NASDAQ:EXAC) : August 1, 2017
finance.yahoo.com - August 1 at 7:10 PM
americanbankingnews.com logoGabelli Weighs in on Exactech, Inc.'s FY2019 Earnings (EXAC)
www.americanbankingnews.com - August 1 at 3:30 PM
americanbankingnews.com logoExactech's (NASDAQ:EXAC) Buy Rating Reiterated at Gabelli
www.americanbankingnews.com - July 31 at 9:22 PM
finance.yahoo.com logoExactech, Inc. breached its 50 day moving average in a Bearish Manner : EXAC-US : July 31, 2017
finance.yahoo.com - July 31 at 6:14 PM
finance.yahoo.com logoEdited Transcript of EXAC earnings conference call or presentation 28-Jul-17 2:00pm GMT
finance.yahoo.com - July 29 at 5:39 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Announces Earnings Results, Meets Expectations
www.americanbankingnews.com - July 29 at 1:52 PM
News IconBRIEF-Exactech Q2 earnings per share $0.33
www.businessinsider.com - July 28 at 9:42 PM
seekingalpha.com logoExactech's (EXAC) CEO David Petty on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - July 28 at 9:42 PM
finance.yahoo.com logoInvestor Network: Exactech, Inc. to Host Earnings Call
finance.yahoo.com - July 28 at 4:37 PM
finance.yahoo.com logoExactech posts 2Q profit
finance.yahoo.com - July 28 at 4:37 PM
americanbankingnews.com logoExactech, Inc. (NASDAQ:EXAC) Releases FY17 Earnings Guidance
www.americanbankingnews.com - July 27 at 9:40 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Issues Q3 Earnings Guidance
www.americanbankingnews.com - July 27 at 9:40 PM
finance.yahoo.com logoExactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue
finance.yahoo.com - July 27 at 7:00 PM
finance.yahoo.com logoExactech, Inc. breached its 50 day moving average in a Bullish Manner : EXAC-US : July 18, 2017
finance.yahoo.com - July 18 at 7:57 PM
americanbankingnews.com logo Exactech, Inc. (EXAC) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - July 18 at 11:34 AM
finance.yahoo.com logoExactech Schedules Second Quarter 2017 Earnings Release and Conference Call
finance.yahoo.com - July 13 at 7:49 PM
streetinsider.com logoExactech (EXAC) Gains FDA 510(k) Clearance for ExactechGPS Shoulder Application
www.streetinsider.com - May 16 at 10:02 PM
marketwatch.com logoVentricular Assist Device (VAD) Market Forecast 2017-2027
www.marketwatch.com - May 2 at 7:32 PM
reuters.com logoBRIEF-Exactech reports Q1 earnings per share $0.32
www.reuters.com - April 27 at 10:43 PM
marketbeat.com logoExactech posts 1Q profit
marketbeat.com - April 25 at 4:47 PM
prnewswire.com logoGlobal Market Study on Hip Replacement: North America to Register a CAGR of 4.3% Between 2016 and 2024
www.prnewswire.com - March 16 at 11:28 PM
biz.yahoo.com logoEXACTECH INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 8 at 5:56 PM
bizjournals.com logoKnee Implant Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
www.bizjournals.com - March 7 at 4:55 PM
seekingalpha.com logoExactech's (EXAC) CEO David Petty on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - February 22 at 5:22 PM



Exactech (EXAC) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.